ICICI Bank Sharp Hike in Minimum Balance Requirement: Policy Shift and Customer Impact
In a major policy change, ICICI Bank, India’s second-largest private lender, has significantly raised its Minimum Average Balance (MAB) requirements across metro, urban, semi-urban, and rural branches. Effective August 2025, the hike comes with stricter penalties and revised transaction rules, making it a crucial development for millions of account holders. This move makes ICICI Bank the first among private banks to implement such a steep increase, prompting concerns and debates over the banking cost burden on common customers.
ICICI Bank has increased the MAB drastically for different types of locations
This change applies to all new accounts opened starting August 2025. The increase represents a fivefold jump in some cases, far exceeding industry norms.
Failure to maintain the MAB will now attract a penalty of,
OR
This penalty structure is stricter than those in many public sector banks, some of which have moved to waive such penalties entirely.
While ICICI Bank tightens MAB rules, many PSBs have taken the opposite approach,
Along with the MAB hike, ICICI Bank has implemented new cash transaction limits,
3 free cash deposits per month
After that, ₹150 per transaction is charged
Complimentary deposit limit: ₹1 lakh/month
Above ₹1 lakh: ₹3.5 per ₹1,000 or ₹150, whichever is higher
If both number and value limits are breached, higher charge applies
The MAB hike is likely to impact low- and middle-income account holders, especially in urban areas where the ₹50,000 minimum may be unaffordable for many.
The penalty system and transaction fees could lead to higher overall banking costs.
Customers may consider switching to PSBs, which offer more relaxed rules on minimum balances and penalties.
The ICC U19 Women’s T20 World Cup 2027 is set to commence on January 21,…
Iodine Deficiency Day or World Iodine Deficiency Disorders Prevention Day is celebrated on October 21…
There is an imported case of the Bundibugyo strain of the Ebola virus in the…
On October 21, 2026, the Drugs Controller General of India (DCGI) approved Zytorvi (toripalimab) in…
India was ranked third in the Ipsos Quality of Care Perception Index 2026 after Malaysia…
Jamnagar is a coastal city in the state of the Gujarat and it is emerging…